Could a shot end peanut allergies? early safety trial begins

NCT ID NCT05476497

First seen Mar 15, 2026 · Last updated May 14, 2026 · Updated 8 times

Summary

This early-stage study tests a new treatment called VLP Peanut to see if it is safe and tolerable for people with peanut allergies. It includes both healthy volunteers and those allergic to peanuts. The goal is to check for side effects and get an early look at whether the treatment might reduce allergic reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Trio Clinical Trials, LLC.

    Houston, Texas, 77008, United States

  • University of Arizona

    Tucson, Arizona, 85724, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of South Florida

    Tampa, Florida, 33613, United States

  • University of Wisconsin School of Medicine and Public Health Asthma, Allergy, and Pulmonary Clinical Research

    Madison, Wisconsin, 53792-9988, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63141, United States

Conditions

Explore the condition pages connected to this study.